Issue link:

Contents of this Issue


Page 7 of 42

In addition to reviewing highlights of RDD® Europe 2023, the article discusses RDD 2024. The conference will be held at the JW Marriott Starr Pass, in Tucson, Arizona, United States, May 5-9, 2024. The conference will use a four-day format, allowing in-depth presentations, discussion of pioneering science and opportunities for networking in a collegial and business-friendly resort setting. 6 OctOber 2023 Inhalation CROSS-INDUSTRY Organizations Expanded online access Twelve Workshops, Posters on the Podium and a meeting of the AAPS Inhalation and Nasal Com- munity rounded out a productive and busy conference with more content than could be absorbed in three days. Fortunately, a leg- acy of the pandemic is that many presentations, posters and work- shops were accompanied by on-demand versions that could be viewed by delegates long after the in-person conference ended. In addition, delegates will con- tinue to have access to more than 2,800 peer-reviewed articles in the RDD library, including those from RDD Europe 2023. In fact, during the conference, anyone (not just delegates) had access to online Company Profiles from Exhibitors, Workshop Present- ers, and Conference Supporters whose financial generosity made it possible to deliver the program described above. Sincere thanks Food and drinks were served from various locations for lunches and breaks to encourage interactions among attendees. Informal net- working continued during the gala dinner at the beautiful Bastide du Roy, with unexplained sculptures of giant blue snails in an adjacent field sparking many conversations. Our sincere thanks to all dele- gates, sponsors, media partners, reviewers, moderators and helpers at RDD Europe 2023. We look forward to seeing you all again at RDD 2024. provided a great introduc- tion to the Bench to Bedside Knowledge Space. • Speakers in the Aqueous Agenda: Navigating Nasal, Inspiring Dry Powder Inhala- tion, and Building a Sustain- able Future Knowledge Spaces presented insights on all the major inhalation and nasal plat- form technologies. Low global warming potential (GWP) pro- pellants and inhaler sustain- ability was the focus of a lively Explore with Experts session. • Alternative bioequivalence ap- proaches dominated the Ad- vanced Inhalation: Data Driven Design Knowledge Space, with Will Ganley (Nanopharm) and Bryan Newman (U.S. Food and Drug Administration) sharing their expertise. • Each of these Knowledge Space program themes carried over to the lively Poster and Exhibi- tion space where 62 companies showcased their innovations alongside 55 posters. One of those posters was presented by Patricia Henriques, a PhD stu- dent at the University of Coim- bra, Portugal, who was selected as the 2023 VCU RDD Peter R. Byron Graduate Student Award winner for her poster and cor- responding paper entitled, "Benchmarking of particle engi- neering strategies for nasal pow- der delivery: Characterization of nasal deposition using the Alberta idealized nasal inlet." Respiratory Drug Delivery (RDD ® ) Europe 2023 ( /rddeurope2023) was a memorable conference for the more than 420 delegates who assembled in An- tibes, France this spring. ey had traveled from 28 countries to learn and discuss the latest science and technology, so vital to the devel- opment of successful inhaled and nasal drug products. e Palais des Congrès Antipolis and the adjacent AC Ambassadeur Hotel, where most delegates stayed, ensured those working in corporate R&D, business development and manage- ment had opportunities to network with each other, along with aca- demics, regulators, clinicians and consultants active across all facets of respiratory drug delivery. Approximately 175 delegates par- ticipated for the first time, min- gling with RDD regulars who have been attending for more than 30 years. Several "first-tim- ers" expressed surprise at how vibrant and expansive Respira- tory Drug Delivery Europe 2023 was. Knowledge Spaces, pioneered during the pandemic and now an established feature of RDD conferences, brought people and organizations with shared interests together, both in the congress cen- ter and via the conference website. Select highlights • Martin Tobin (University of Leicester, UK), the keynote speaker, shared up-to-the- minute analyses implicating genes and pathways influenc- ing pulmonary disease, which A review of RDD ® Europe 2023 and look ahead to RDD 2024 The Organizers of the Respiratory Drug Delivery Conference Series

Articles in this issue

view archives of Inhalation - INH1023